Amsterdam, the Netherlands - Royal Philips Electronics today
announced that it will lead a new European Union (EU) funded
research project aimed at improving care of heart patients through
the development of innovative telemonitoring solutions. Following
the highly successful MyHeart project, the HeartCycle project will
start on March 1, 2008, and will be one of the largest biomedical
and healthcare research projects within the EU.
The HeartCycle consortium will work to improve the quality of care
for coronary heart disease and heart failure patients by developing
systems for monitoring their condition at home and involving them in
the daily management of their disease. These systems will comprise
unobtrusive sensors built into the patient’s clothing or bed sheets
and home appliances such as weight scales and blood pressure
monitors. The consortium aims to develop dedicated software that
analyzes the acquired data, and that can be programmed to provide
feedback on the patient’s health status, plus his or her adherence
to prescribed therapies and progress towards achieving health status
milestones. It also aims to develop mechanisms to report relevant
data back to clinicians automatically so that they can prescribe
personalized therapies and lifestyle recommendations.
Public and private partners from 18 research, academic, industrial
and medical organizations from nine different European countries and
China will team up in the project. HeartCycle will run for four
years and has a budget of approximately EUR 21 million, of which
approximately EUR 14 million will be funded by the European Union as
part of the EU 7th Framework Program.
Cardiovascular disease kills around 1.9 million people every year in
the EU, with the associated annual health costs estimated at EUR 105
billion. Around half of these deaths occur in people who have
previously had a heart attack, most of whom will develop heart
failure before they die. There are currently around 10 million heart
failure patients in the EU and it is one of the commonest medical
reasons for hospitalization in adults. Finding better ways to manage
and treat coronary heart disease and chronic heart failure is
therefore seen as one of the most effective ways of reducing the
human cost and financial burden of these debilitating conditions.
“The greatest challenge and opportunity for the management of
long-term medical conditions is to help patients to help
themselves,” says Professor John Cleland MD, Head of the Department
of Cardiology at the University of Hull (UK), past chairman of both
the Working Group on Heart Failure of the European Society of
Cardiology and of the British Society for Heart Failure and Chief
Medical Officer of the HeartCycle project. “Investing directly in
people who need help, and not just in services that do things to or
for them, makes sense in terms of improved care, greater
affordability and the effective deployment of scarce nursing and
medical resources.”
“By developing systems that remotely monitor heart patients and
motivate them to adhere to treatment regimes and adopt beneficial
lifestyles, we hope to improve the survival of people with heart
disease as well as to contain the overall cost of care,” says Henk
van Houten, senior vice president of Philips Research and head of
the Healthcare Research program. “The development of such systems
can only be achieved efficiently via multi-disciplinary partnerships
between hardware engineers, software engineers, textile
manufacturers, industrial designers, clinical experts and healthcare
providers, as is the case in the HeartCycle project.”
HeartCycle Consortium membership (in alphabetical order)
Aristotle University of Thessaloniki (Greece); Clothing Plus Oy
(Finland); CSEM Centre Suisse D'electronique Et De Microtechnique Sa
(Switzerland); Empirica Gesellschaft für Kommunikations und
Technologieforschung mbH (Germany); Faculdade Ciencias e Tecnologia
da Universidade de Coimbra (Portugal); Fundación Vodafone España
(Spain); Hospital Universitario Clínico San Carlos (Spain);
Instituto de Aplicaciones de las Tecnologías de la Información y de
las Comunicaciones Avanzadas (Spain); Medtronic Ibérica SA (Spain);
Philips Electronics Nederland B.V. (The Netherlands); Philips
Research (Germany); Politecnico Di Milano - Dipartimento di
Bioingegneria (Italy); Rheinisch Westfälische Technische Hochschule
(Germany); T-Systems ITC Iberia SA (Spain); Universidad Politécnica
de Madrid (Spain); Chinese University of Hong Kong (China);
University of Hull (United Kingdom); Valtion Teknillinen
Tutkimuskeskus (Finland).
The earlier MyHeart project developed advanced telemonitoring
technologies and service concepts to enable people to play an active
role in maintaining their health. In the course of the MyHeart
project, home-based disease management was identified as a potential
opportunity for improving medical standards of care. The HeartCycle
project aims to extend this disease management concept for specific
patient groups with a focus on improving patient compliance to
medication and lifestyle therapies.
Steve Klink
Communications Department Philips Research
Tel.: +31 40 27 43703
Mobile: +31 6 10888824
E-mail: steve.klink@philips.com
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a
global leader in healthcare, lighting and consumer lifestyle, delivering
people-centric, innovative products, services and solutions through the brand
promise of “sense and simplicity”. Headquartered in the Netherlands, Philips
employs approximately 134,200 employees in more than 60 countries worldwide.
With sales of EUR 27 billion in 2007, the company is a market leader in medical
diagnostic imaging and patient monitoring systems, energy efficient lighting
solutions, as well as lifestyle solutions for personal wellbeing. News from Philips is located at
www.philips.com/newscenter.